Notes - Segment Information, Etc.

ROHTO PHARMACEUTICAL CO.,LTD. - Filing #7295708

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Notes - Segment information, etc.
Segment information
Disclosure of sales and profit (loss) for each reportable segment
Sales
Revenues from external customers
37,906,000,000 JPY
8,030,000,000 JPY
81,442,000,000 JPY
1,658,000,000 JPY
137,423,000,000 JPY
10,043,000,000 JPY
139,082,000,000 JPY
139,082,000,000 JPY
JPY
8,765,000,000 JPY
34,223,000,000 JPY
76,411,000,000 JPY
7,047,000,000 JPY
127,869,000,000 JPY
127,869,000,000 JPY
JPY
1,421,000,000 JPY
126,448,000,000 JPY
Transactions with other segments
2,479,000,000 JPY
61,000,000 JPY
1,852,000,000 JPY
54,000,000 JPY
5,250,000,000 JPY
856,000,000 JPY
JPY
5,304,000,000 JPY
-5,304,000,000 JPY
842,000,000 JPY
2,274,000,000 JPY
1,541,000,000 JPY
43,000,000 JPY
4,715,000,000 JPY
JPY
-4,715,000,000 JPY
13,000,000 JPY
4,702,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.